Brief: Simcere Pharmaceutical Sees Revenue Of RMB6,289 Mln To RMB6,349 Mln For FY2022

Simcere Pharmaceutical

24/02/2023 10:11

Feb 24 (Reuters) - Simcere Pharmaceutical Group Ltd
 2096.HK :
    * SEES  REVENUE OF APPROXIMATELY RMB6,289 MILLION TO
RMB6,349
MILLION FOR FY2022
    * SEES  PROFIT ATTRIBUTABLE OF RMB904 MILLION TO RMB964
MILLION
FOR FY2022
    * SEES  PROFIT ATTRIBUTABLE OF APPROXIMATELY RMB904 MILLION
TO
RMB964 MILLION FOR FY2022

Further company coverage:  2096.HK 
 ((Reuters.Briefs@thomsonreuters.com;))